TIWN

Washington, March 23 (TIWN) The US Food and Drug Administration (FDA) has authorised the first-ever rapid test that can diagnose COVID-19 disease in 45 minutes.
The authorization was made Friday and tests will begin shipping next week, according to a statement from California-based Cepheid, the company manufacturing the tests.
"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities," said Dr. David Persing, MD, Ph.D., chief medical and technology officer at Cepheid.
"An accurate test delivered close to the patient can be transformative -- and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources," Persing added.
- Russia dismisses Trump's warning on announcement of imposing sanctions
- An archeological heritage, Satyajit Ray's family home set for demolition in Bangladesh
- Pakistan: Baloch rights group spotlights surge in human rights violations in Balochistan
- Minority rights group decries deep-rooted religious intolerance in Pakistan
- Afghan authorities destroy 65 tonnes of expired food items in Kabul